Use of alternative and complementary therapies in children with cancer

Pediatric Blood and Cancer

Volumn 44, Issue 7, 2005, Pages 660-668

  Martel, Dominique ^a   Bussières, Jean François ^a   Théorêt, Yves ^a   Lebel, Denis ^a   Kish, Sandra ^a   Moghrabi, Albert ^a   Laurier, Claudine ^b  

^a UNIVERSITY OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Alternative therapies; Complementary therapies; Cross sectional studies; Oncology; Pediatrics; Quality of life

Indexed keywords

HERBACEOUS AGENT; VITAMIN;

ADOLESCENT; ADULT; ALTERNATIVE MEDICINE; CHILD; CHILD BEHAVIOR; CHILDHOOD CANCER; CONFERENCE PAPER; DEMOGRAPHY; DISEASE COURSE; FEMALE; HERBAL MEDICINE; HOMEOPATHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MENTAL HEALTH; NUTRITIONAL STATUS; PHYSIOTHERAPY; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; SIDE EFFECT; WELLBEING;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; COMPLEMENTARY THERAPIES; CROSS-SECTIONAL STUDIES; DEMOGRAPHY; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MEDICINE, HERBAL; NEOPLASMS; QUALITY OF LIFE; QUESTIONNAIRES; SOCIOECONOMIC FACTORS;

EID: 18244378224     PISSN: 15455009     EISSN: None     Source Type: Journal    
DOI: 10.1002/pbc.20205     Document Type: Conference Paper

References (28)

1. Eisenberg DM, Kessler RC, Foster C, et al. Unconventional medicine in the United States. Prevalence, costs, and patterns of use. N Engl J Med 1993;328:246-252.
2. Friedman T, Slayton WB, Allen LS, et al. Use of alternative therapies for children with cancer. Pediatrics 1997;100:E1.
3. Sawyer MG, Gannoni AF, Toogood IR, et al. The use of alternative therapies by children with cancer. Med J Aust 1994;160:320-322.
4. Fernandez CV, Stutzer CA, Mac William L, et al. Alternative and complementary therapy use in pediatric oncology patients in British Columbia: Prevalence and reasons for use and nonuse. J Clin Oncol 1998;16:1279-1286.
5. Neuhouser ML, Patterson RE, Schwartz SM, et al. Use of alternative medicine by children with cancer in Washington state. Prev Med 2001;33:347-354.
6. Bold J, Leis A. Unconventional therapy use among children with cancer in Saskatchewan. J Pediatr Oncol Nurs 2001;18:16-25.
7. Burstein HJ, Gelber S, Guadagnoli E, et al. Use of alternative medicine by women with early-stage breast cancer. N Engl J Med 1999;340:1733-1739.
8. Richardson MA, Sanders T, Palmer JL, et al. Complementary/ alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol 2000;18:2505-2514.
9. Bernstein BJ, Grasso T. Prevalence of complementary and alternative medicine use in cancer patients. Oncology (Huntingt) 2001;15:1267-1272; discussion 1272-8, 1283.
10. Kelly KM, Jacobson JS, Kennedy DD, et al. Use of unconventional therapies by children with cancer at an urban medical center. J Pediatr Hematol Oncol 2000;22:412-416.
11. Yeh CH, Tsai JL, Li W, et al. Use of alternative therapy among pediatric oncology patients in Taiwan. Pediatr Hematol Oncol 2000; 17:55-65.
12. Cassileth BR. The Integrative Medicine Service at Memorial Sloan-Kettering Cancer Center. Semin Oncol 2002;29:585-588.
13. Landgraf JMAL, Ware JE. The CHQ User's Manual. Boston, MA: Health Act; 1999.
14. Waters E, Salmon L, Wake M. The parent-form Child Health Questionnaire in Australia: Comparison of reliability, validity, structure, and norms. J Pediatr Psychol 2000;25:381-391.
15. Raat H, Bonsel GJ, Essink-Bot ML, et al. Reliability and validity of comprehensive health status measures in children: The Child Health Questionnaire in relation to the Health Utilities Index. J Clin Epidemiol 2002;55:67-76.
16. Ernst E, Cassileth BR. The prevalence of complementary/ alternative medicine in cancer: A systematic review. Cancer 1998;83:777-782.
17. Risberg T, Kolstad A, Bremnes Y, et al. Knowledge of and attitudes toward complementary and alternative therapies; a national multicentre study of oncology professionals in Norway. Eur J Cancer 2004;40:529-535.
18. Shumay DM, Maskarinec G, Kakai H, et al. Why some cancer patients choose complementary and alternative medicine instead of conventional treatment. J Fam Pract 2001;50:1067-1078.
19. Ben-Arye E, Frenkel M, Margalit RS. Approaching complementary and alternative medicine use in patients with cancer: Questions and challenges. J Ambul Care Manage 2004;27:53-62.
20. Rivera JOOM, Lawson ME, Verma KM. Evaluation of the use of complementary and alternative medicine in the largest United States-Mexico border city. Pharmacotherapy 2002;22:256-264.
21. Maskarinec G, Shumay DM, Kakai H, et al. Ethnic differences in complementary and alternative medicine use among cancer patients. J Altern Complement Med 2000;6:531-538.
22. Boon H, Stewart M, Kennard MA, et al. Use of complementary/ alternative medicine by breast cancer survivors in Ontario: Prevalence and perceptions. J Clin Oncol 2000;18:2515-2521.
23. Cassileth BR, Lusk EJ, Guerry D, et al. Survival and quality of life among patients receiving unproven as compared with conventional cancer therapy. N Engl J Med 1991;324:1180-1185.
24. Paltiel O, Avitzour M, Peretz T, et al. Determinants of the use of complementary therapies by patients with cancer. J Clin Oncol 2001;19:2439-2448.
25. Risberg T, Lund E, Wist E, et al. The use of non-proven therapy among patients treated in Norwegian oncological departments. A cross-sectional national multicentre study. Eur J Cancer 1995;31A: 1785-1789.
26. Risberg T, Lund E, Wist E. Use of non-proven therapies. Differences in attitudes between Norwegian patients with non-malignant disease and patients suffering from cancer. Acta Oncol 1995;34:893-898.
27. Connolly MA, Johnson JA. Measuring quality of life in paediatric patients. Pharmacoeconomics 1999;16:605-625.
28. Shapiro DASM. Integrating complementary therapies into a traditional oncology practice. Oncology Issues 2002;17:35-40.